Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology, addresses how the pandemic may have influenced cancer screening and diagnosis rates.
Anecdotally, we are starting to see later-stage cancer diagnoses, but right now it’s hard to quantify the true extent. It may take years to fully comprehend, or appreciate, how pandemic-related screening delays led to later-stage diagnoses, noted Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology,
Transcript
Have pandemic-related screening drop-offs resulted in later-stage diagnoses?
I am seeing that cancers are being diagnosed at a later stage. I would say it’s anecdotal at this point, because I think that some of these changes are going to take years to really see the long-term effects. But we are already seeing it. I have many patients that presented late stage and tell me that they delayed screening because of the pandemic, and then they have a late-stage cancer. And I will say that we worked with the Community Oncology Alliance to write up some of these that were published in The Washington Post.
When can we expect to see some hard data that this is real?
I’m not sure who’s looking at the different stages at diagnosis, because it’s hard to quantify that. I think that very soon you’ll continue to see cancer reporting. You know, we have a certain estimated number of cancers every year. When we see decreases in that estimated number of cancer, we’ll know that those cancers remain undiagnosed. I think somewhat we’ll first see, the stage migration, or cancers presenting at a later stage. I think this is something that will probably take years to really, truly appreciate.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More